VipStockReports

Stocks on Trader's Radar - Celsion Corporation (NASDAQ:CLSN), Riverbed Technology, Inc.(NASDAQ:RVBD), Idenix Pharmaceuticals Inc(NASDAQ:IDIX), TiVo Inc.(NASDAQ:TIVO)

 
Repost This

Middletown, DE -- (SBWIRE) -- 09/18/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Celsion Corporation (NASDAQ:CLSN), Riverbed Technology, Inc.(NASDAQ:RVBD), Idenix Pharmaceuticals Inc(NASDAQ:IDIX), TiVo Inc.(NASDAQ:TIVO)

Celsion Corporation (NASDAQ:CLSN) gained volume of 1.95 million shares and the average volume of the stock remained 2.12 million shares. The 52 week range of the stock remained $0.75 - $9.44 and the day range was $1.21 - $1.27.The stock opened the session at $1.26, and closed the session at $01.21. The stock showed a negative performance of -3.97% in previous trading session. Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology.

Has CLSN Found The Bottom and Ready To Move Up? Find Out Here

In previous session, Riverbed Technology, Inc.(NASDAQ:RVBD) traded 1.94 million shares and the average volume of the stock remained 2.99 million shares. The 52 week range of the stock remained $13.83 - $24.23. The stock was a bull and advanced +1.04%, while its closing price stayed at $15.59. The market capitalization of the stock remained 2.56 billion. The half-yearly trend of the stock remained positive +4.63%. Riverbed Technology, Inc. provides solutions to the fundamental problems associated with information technology (IT) performance across wide area networks (WANs) in the United States and internationally. It offers Steelhead products, which enable customers to enhance the performance of applications and access data across WANs.

For How Long RVBD will fight for Profitability? Read This Trend Analysis report

Idenix Pharmaceuticals Inc(NASDAQ:IDIX) volume of the stock was 1.92 million shares in the most recent session and the average volume remained 984,954.00 shares. The stock boosted +6.21% and finished the prior session at the closing price of $5.64. The stock traded 1.92 million shares in its previous trading session and its average volume remained 984,954.00 shares. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV).

Will IDIX Continue To Move Higher? Find Out Here

TiVo Inc. (NASDAQ:TIVO) traded with volume of 1.85 million shares and the average volume of the stock remained 2.92 million shares. The stock grew +1.15% and finished the trading at $12.29. The market capitalization of the stock remained 1.50 billion. The beta of the stock remained 1.43. TiVo Inc., together with its subsidiaries, provides software and service technology that enables the distribution of video content on digital video recorders (DVRs), non-DVR set-top boxes (STB), computers, smartphones, and tablets in the United States and internationally.

Why Should Investors Buy TIVO After The Recent Gain? Just Go Here and Find Out

About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/